Measure | Domain | Enrollment | Baseline | Sessions 1-16 | Mid-treatment week 12 | 28-week assessment | 36-week assessment | 48-week assessment |
---|---|---|---|---|---|---|---|---|
Informed consent | Â | X | Â | Â | Â | Â | Â | Â |
Screen | Â | X | Â | Â | Â | Â | Â | Â |
Primary outcome | Â | Â | Â | Â | Â | Â | Â | Â |
CAPS | PTSD Dx & Symptom Severity | Â | X | Â | Â | X | X | X |
Secondary outcomes | Â | Â | Â | Â | Â | Â | Â | Â |
IIP | Interpersonal problems | Â | X | Â | X | X | X | X |
DERS | Emotion regulation | Â | X | Â | X | X | X | X |
GAF | Functional status | Â | X | Â | Â | X | X | X |
Baseline psychopathology | Â | Â | Â | Â | Â | Â | Â | Â |
SCID I | Axis I disorders | Â | X | Â | Â | X | X | X |
SCID-II Screen | Axis II disorders | Â | X | Â | Â | X | Â | Â |
BSI | General distress | Â | X | Â | X | X | X | X |
SF-36 | Subjective health functioning | Â | X | Â | Â | X | X | X |
HSUF | Recent and ongoing health service utilization | Â | X | Â | Â | X | X | X |
Treatment and treatment process | Â | Â | Â | Â | Â | Â | Â | Â |
PCL-5 | PTSD self-report | Â | X | Alternate sessions | X | X | X | X |
TSI-Diss | Dissociation self-report | Â | X | Alternate sessions | X | X | Â | Â |
WAI | Therapeutic alliance | Â | Â | Â | Sessions 1 to 5 | X | Â | Â |
TES | Satisfaction with treatment and environment | Â | Â | Â | Â | X | Â | Â |